Comments to the 2020 closing and 2021 update by CEO Axel Sjöblad.
About Tina Dackemark Lawesson
This author has not written his bio yet.
But we are proud to say that Tina Dackemark Lawesson contributed 55 entries already.
Entries by Tina Dackemark Lawesson
Click image to read the newsletter.
At this year’s Society of Toxicology annual meeting SenzaGen’s in vitro Medical Device test method was awarded the Best Overall Abstract Award in the Medical Device and Combination Product Specialty Section. Authors Joshua J. Schmidt, Ph.D. Ron Brown Rose-Marie Jenvert, PhD Abstract 3020: Poster Board – P158: Applicability Domain of the GARDskin Medical Device Test […]
In this interview CEO Axel Sjöblad comments the 2020 year-end report, ongoing projects, and the way forward.
Are you attending the 2021 SOT Annual Meeting and ToxExpo? Come join our workshop presentation, hosted session and poster presentations to hear the latest news about GARD™ and how the assays are used for skin sensitization testing! Click image for more details about the program!
SenzaGen’s sales during the full year 2020 tripled compared to 2019. Listen to CEO Axel Sjöblad commenting the 2020 performance in today’s conference call. Listen to CEO comment
Thanks to all who attended our webinar ‘Why choose GARD for skin sensitization testing?’ last week. If you were not able to attend live, and wish to watch it, you can now access the webinar’s recording! Watch recording here!
We wish you a truly happy holiday season, and we look forward to seeing you again in the new year. 2020 Highlights SenzaGen received GLP approval We can now offer GLP-compliant test services using the GARD™platform. Read more GARD™skin Dose-Response This newly released assay provides quantitative potency information related to skin sensitization. Learn more […]
Our CEO Axel Sjöblad gave an update on our commercial progress at Redeye Life Science Day last week. Watch the replay here:
Here is an interview with Principal Scientist Gretchen Ritacco, MS, explaining why RIFM has focused some of its research on the potential for light to activate fragrance materials resulting in reactions in the body’s largest organ, the skin. Since June 2020, SenzaGen and the Research Institute for Fragrance Materials (RIFM) are collaborating to investigate in […]